Veterinary grade compound tar acid solution is supplied as a controlled-composition active raw material containing phenol, three cresol isomers, xylenols and a defined neutral oil fraction. The application blocks below are restricted to environmental disinfection, topical antisepsis and parenteral preservation where species-specific safety data, residue legislation and national biocidal authorisations support use. Tablet, capsule, powder, granule and premix presentations are non-systemic environmental delivery matrices; oral administration in food-producing animals is not implied unless a national dossier explicitly includes that use and establishes a valid withdrawal period.

In multi-dose parenteral manufacturing, compound tar acid solution is introduced as a preservative-active raw material rather than as a primary therapeutic entity. The acceptance criteria of USP <51> and Ph. Eur. 5.1.3 are applied to the final injectable formulation, requiring not less than 1.0 log reduction for bacterial challenge strains by day 7 and no recovery at days 14 and 28 for yeast and mould. The total tar acid content in the finished injection is controlled to ≤0.5% w/v, a boundary derived from parenteral tolerability data, with lower limits mandated when the product is intended for food-producing species and withdrawal periods are assigned under Regulation (EU) 2019/6. The concentrate is pre-filtered through 0.45 µm polyvinylidene fluoride cartridges to remove neutral oil precipitates, then metered into the aqueous phase at 20–25 °C under a nitrogen overlay to limit oxidation of cresol isomers. Final sterilisation by moist heat at 121 °C for 15 min is preceded by gas chromatography-flame ionisation detection assay of phenol and the three cresol isomers, because steam volatility can shift the phenol-to-cresol ratio enough to alter preservative efficacy. Terminal product types include multi-dose bovine mastitis injection suspensions, equine joint lavage injections and companion-animal antibiotic reconstructions.

On production-scale filling lines, phase separation has been recorded in silicone transfer tubing when total tar acid content exceeds 0.5% w/v and when batch temperature falls below 4 °C during holding. Polysorbate 80, when present above 1.0% w/v, produces visible turbidity within 48 h; formulators are advised to replace it with tocopheryl polyethylene glycol succinate or to reduce the tar acid addition accordingly. Autoclave cycle validation must be repeated after any change in tar acid supplier because neutral oil content and cresol isomer distribution vary by ±3% between coal tar batches. These operational boundaries are mandatory for GMP batch release under EU GMP Annex 15.

What Concentration Range Withstands Organic Soiling in Dairy Holding Pens?

Dairy holding-pen surfaces, parlour walls and collection-yard floors impose a high organic load that neutralises phenolic actives through protein binding and pH shift. Dilutions of the concentrate are validated under EN 1656:2019 with 3.0 g/L bovine albumin dirty conditions and under EN 1657:2016 against Candida albicans and Aspergillus brasiliensis. A clean-surface application rate of 1% v/v active solution at 0.2 L/m² is sufficient when physical pre-cleaning removes gross manure; for soiled concrete with residual milk fat, the concentration is raised to 2% v/v at 0.4 L/m² and contact time is extended to 30 min at 10 °C. The concentrated disinfectant is manufactured in 316L stainless steel vessels by high-shear mixing of tar acid solution with alkali-saponified rosin or soap at 60–70 °C, then cooled and filled into HDPE drums under nitrogen blanketing. Terminal product types are liquid farm disinfectant concentrates, ready-to-use parlour sprays, foaming wall sanitisers and IBC-level dilutable solutions.

Application in milking parlours with overhead foam lances operating at 4–6 bar produces a median droplet size of 100–120 µm, which reduces aerosolisation of phenolic actives. An operational incompatibility is observed with cationic quaternary ammonium co-disinfectants, which form insoluble complexes with saponated tar acids and produce filter-clogging precipitates in low-pressure lines. Batch-to-batch variance in soap level alters the phase-stability temperature: if the cloud point falls below 15 °C, the diluted disinfectant separates and efficacy under EN 1656:2019 drops. Concentrate drums are stored above 5 °C and below 35 °C.

Effervescent Matrices and Granular Carrier Load Capacities

Production of effervescent disinfectant tablets begins with liquid adsorption of compound tar acid solution onto a hydrophobic fumed silica and microcrystalline cellulose carrier. A final tablet containing 15–25% w/w tar acid solution equivalent is compressed on a 27-station rotary tablet press at 25–35 kN and maintained at ≤1.0% friability per Ph. Eur. 2.9.7. One 50 g tablet delivered to 10 L water produces a final tar acid active range of 0.3–0.5% w/v, which is then verified by the end-user against EN 1656:2019 under dirty conditions. For granular footbath concentrates, the carrier is sepiolite or expanded perlite with a post-spray moisture content of ≤8% by Karl Fischer titration; the granules are cured in sealed silos for 24 h at 20–25 °C to allow diffusion into the porous core. Terminal product types include effervescent disinfectant tablets, granular footbath concentrates, water-soluble PVOH film sachets and bulk granular premix for automated dilutors.

Magnesium stearate above 1.0% w/w in the tablet formulation causes hydrophobic film formation and retards effervescent disintegration; sodium stearyl fumarate at 0.5–2.0% w/w is substituted where high-speed compaction is required. When tableting runs exceed 4 h at ambient relative humidity above 60%, free moisture uptake on the carrier generates pre-compression capping and a batch failure rate above 5%. Encapsulated single-dose formats for water-soluble capsules have limited published compatibility data with high-pH tar acid systems; compatibility must be tested with PVOH films at pH 8.5–9.5 and wall thickness of 40–60 µm before production commitment.

After depopulation and physical removal of bedding, the residual surface film in swine farrowing rooms and poultry houses is treated with a diluted compound tar acid solution prior to high-pressure washing and again after rinsing. The virucidal benchmark is EN 14675:2015, with a mandatory 30 min contact at 10 °C using 0.3% w/v bovine albumin dirty conditions, and the bactericidal benchmark is EN 1656:2019. For porous concrete, a 2% v/v solution is applied at 0.4 L/m²; for painted metal and sealed epoxy floors, 1% v/v at 0.2 L/m² is sufficient. Application through low-pressure fan nozzles producing 100–150 µm droplets at 3–5 bar provides recoverable wetting without excessive aerosol. Terminal product types include liquid disinfectant concentrates, foaming farm disinfectants, powdered spot treatments for wet pits and effervescent tablet dilutions for portable footbaths.

Thermal fogging is not recommended because phenolic actives degrade under hot-surface contact above 200 °C and generate phenolic resin deposits on fan housings. In deep-pit barns with ammonia concentrations above 25 ppm, the pH of the diluted disinfectant shifts from 8.5–9.5 to below 7.9, reducing the ionisation state and bactericidal rate; a pre-rinse with clean water and increased ventilation is required. Batch monitoring shows that re-use of footbath solutions containing more than 10% suspended solids fails EN 1656:2019 after the first 12 h; disposal and recharge are recommended at that threshold.

Dilution Limits for Epidermal Contact in Claw and Wound Hygiene

When the tar acid solution is diluted for direct skin contact in cattle claw hygiene or superficial wound lavage, the final total tar acid concentration is restricted to 0.1–0.3% w/v and the solution is buffered to pH 8.0–8.5 with citric acid. Dermal safety is assessed under OECD 404 acute dermal irritation/corrosion and repeated-dose dermal studies, while antimicrobial activity is verified under EN 1040:2005 for basic bactericidal activity. For hoof gels and poultices, the tar acid solution is incorporated at 0.5–1.0% w/w into a clay or carbomer base at 25 °C with slow paddle mixing to avoid localised concentration spikes. Terminal product types are buffered wound lavages, claw spray solutions, hoof gel poultices and non-sterile topical antiseptic bottles.

Feline toxicity is an absolute operational boundary; phenolic compounds are contraindicated for feline skin due to deficient glucuronidation capacity, and incidental contact with treated surfaces at 0.1% w/v has been associated with adverse neurological signs in published veterinary toxicology reports. Product labels and safety data sheets are expected to state this species restriction explicitly under REACH Annex II provisions. For food-producing species, topical application must be followed by a withdrawal period determined under Regulation (EU) 2019/6; published data for this specific configuration is limited for lactating dairy animals, requiring residue depletion studies before marketing.

If Dry Premix Carriers Are Stored Above 75% Relative Humidity

If dry premix carriers are stored above 75% relative humidity, moisture uptake initiates agglomeration and releases free tar acid to the surface of the granule. The carrier system is produced by spraying compound tar acid solution at 5–10% w/w onto expanded perlite or sepiolite in a ribbon blender operating at 15 rpm for 20 min, followed by sealed-silo curing for 24 h at 20–25 °C and packaging in 25 kg valve bags with an inner polyethylene liner. The final free-moisture specification is ≤8% by Karl Fischer titration, and efficacy is verified under EN 1656:2019 and EN 1657:2016 after dust extraction. Terminal product types include barn floor powders, deep-pit granule treatments, premix carriers for footbath stations and dust-free treated perlite. Under EU Biocidal Products Regulation (EU) No 528/2012, the product falls under Product Type 3 veterinary hygiene and requires national authorisation or transitional listing for the active substance before placing on the EU market.

Ribbon blender mixing beyond 20 min generates particle size reduction below 150 µm, increasing airborne respirable dust and altering the dust-free claim; batch sampling on production-scale mixers has shown dust fractions above 2% w/w when mixing time exceeds 30 min. The use of alkaline carriers such as sodium carbonate-treated perlite is incompatible with acidic tar acid fractions because local neutralisation raises pH above 9.5 and precipitates free phenol; carrier pH should remain below 8.0 before spraying. In high-humidity regions, a secondary desiccant sachet in the valve bag maintains free moisture below 8% for 12 months; without it, field failures include caking and reduced dispersibility in footbath water.